Department of Anaesthesiology, University Hospital Regensburg, 93042 Regensburg, Germany.
Acta Neurochir (Wien). 2013 Aug;155(8):1417-24. doi: 10.1007/s00701-013-1801-2. Epub 2013 Jun 28.
Temporary anaesthesia or analgosedation used for awake craniotomies carry substantial risks like hemodynamic instabilities, airway obstruction, hypoventilation, nausea and vomiting, agitation, and interference with test performances. We tested the actual need for sedatives and opioids in 50 patients undergoing awake craniotomy for brain tumour resection in eloquent or motoric brain areas when cranial nerve blocks, permanent presence of a contact person, and therapeutic communication are provided.
Therapeutic communication was based on the assumption that patients in such an extreme medical situation enter a natural trance-like state with elevated suggestibility. The anaesthesiologist acted as a continuous guide, using a strong rapport, nonverbal communication, hypnotic suggestions, such as dissociation to a "safe place", and the reframing of disturbing noises, while simultaneously avoiding negative suggestions. Analgesics or sedatives were at hand according to the principle "as much as necessary, but not more than needed".
No sedation was necessary for any of the patients besides for the treatment of seizures. Only two-thirds of the patients requested remifentanil, with a mean dosage of 96 μg before the end of tumour resection and a total of 156 μg. Hemodynamic reactions indicative of stress were mainly seen during nerve blockades and neurological testing. Postoperative vigilance tests showed equal or higher scores than preoperative tests.
The main challenges for patients undergoing awake craniotomies include anxiety and fears, terrifying noises and surroundings, immobility, loss of control, and the feeling of helplessness and being left alone. In such situations, psychological support might be more helpful than the pharmacological approach. With adequate therapeutic communication, patients do not require any sedation and no or only low-dose opioid treatment during awake craniotomies, leaving patients fully awake and competent during the entire surgical procedure without stress. This approach can be termed "awake-awake-awake-technique".
对于在语言或运动功能区进行的清醒开颅手术,临时麻醉或镇静可能会带来严重的风险,如血流动力学不稳定、气道阻塞、通气不足、恶心呕吐、躁动以及对测试表现的干扰。我们在为 50 名因脑肿瘤而在语言或运动功能区进行清醒开颅手术的患者提供颅神经阻滞、固定联系人的永久存在以及治疗性沟通的情况下,测试了在这种极端医疗情况下患者对镇静剂和阿片类药物的实际需求。
治疗性沟通基于这样一种假设,即在如此极端的医疗情况下,患者会进入一种自然的恍惚状态,暗示性增强。麻醉师充当连续的指导者,通过建立良好的关系、非语言交流、催眠暗示,如分离到“安全的地方”,以及重新构建干扰性噪音,同时避免负面暗示。根据“需要多少就给多少,但不能超过需要”的原则,准备了镇痛剂或镇静剂。
除了治疗癫痫外,没有一位患者需要镇静。只有三分之二的患者需要瑞芬太尼,在肿瘤切除结束前平均剂量为 96μg,总共 156μg。提示应激的血液动力学反应主要发生在神经阻滞和神经测试期间。术后警觉测试显示,分数与术前测试相等或更高。
进行清醒开颅手术的患者面临的主要挑战包括焦虑和恐惧、可怕的噪音和环境、无法移动、失去控制、无助和孤独感。在这种情况下,心理支持可能比药物治疗更有帮助。通过适当的治疗性沟通,患者在清醒开颅手术期间不需要任何镇静,也不需要或仅需要低剂量的阿片类药物治疗,使患者在整个手术过程中保持完全清醒和有能力,没有压力。这种方法可以称为“清醒-清醒-清醒技术”。